Weil, Gotshal & Manges advised Apollo S3 Investment Management, L.P., while Davis Polk & Wardwell and Paul, Weiss, Rifkind, Wharton & Garrison advised Crestview Partners on...
Crestview Partners’ $600 Million Continuation Fund for Two Fund III Investments
GTCR’s $2.7 Billion Acquisition of AssetMark
Kirkland & Ellis and Paul Hastings advised GTCR on the transaction, and Davis Polk & Wardwell advised AssetMark. GTCR, a leading private equity firm with substantial...
Natera’s $250 Million Follow-On Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Natera, and Davis Polk & Wardwell advised the representatives of the several underwriters on the offering. Natera, Inc....
AVITA Medical’s At-The-Market Offering
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...